FDA NDC Directory · JSON-LD · Markdown

daptomycin

NDC 25021-174 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerSagent Pharmaceuticals
Marketing categoryAbbreviated NDA (generic) · App ANDA207104
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsDAPTOMYCIN (50 mg/mL)
Marketing started20191115
Package count2

External sources

Source: openFDA. Public-domain (CC0).